Journal
INTEGRATIVE CANCER THERAPIES
Volume 17, Issue 1, Pages 73-79Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1534735416684016
Keywords
exercise; non-small-cell lung cancer; physical activity; quality of life; small-cell lung cancer
Categories
Funding
- National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (NCATS Grant) [UL1TR000062]
- South Carolina Clinical and Translational Research Institute
- academic home at the Medical University of South Carolina (NIH/NCATS Grant) [UL1TR000062]
Ask authors/readers for more resources
Background and objective. Increasing physical activity (PA) is safe and beneficial in lung cancer (LC) patients. Advanced-stage LC patients are under-studied and have worse symptoms and quality of life (QoL). We evaluated the feasibility of monitoring step count in advanced LC as well as potential correlations between PA and QoL. Methods. This is a prospective, observational study of 39 consecutive patients with advanced-stage LC. Daily step count over 1 week (via Fitbit Zip), QoL, dyspnea, and depression scores were collected. Spearman rank testing was used to assess correlations. Correlation coefficients () >0.3 or <-0.3 (more and less correlated, respectively) were considered potentially clinically significant. Results. Most (83%) of the patients were interested in participating, and 67% of those enrolled were adherent with the device. Of those using the device (n = 30), the average daily step count was 4877 (range = 504-12 118) steps/d. Higher average daily step count correlated with higher QoL ( = 0.46), physical ( = 0.61), role ( = 0.48), and emotional functioning ( = 0.40) scores as well as lower depression ( = -0.40), dyspnea ( = -0.54), and pain ( = -0.37) scores. Conclusion. Remote PA monitoring (Fitbit Zip) is feasible in advanced-stage LC patients. Interest in participating in this PA study was high with comparable adherence to other PA studies. In those utilizing the device, higher step count correlates with higher QoL as well as lower dyspnea, pain, and depression scores. PA monitoring with wearable devices in advanced-stage LC deserves further study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available